Therefore, the aims of our study were to investigate the expression levels of NK1R in the four different molecular subtypes of breast cancer and its relationship with proliferation activity as measured by Ki-67 index and with clinicopathological parameters and overall survival rate. This evidence concerns the gene MKI67 and breast carcinoma.